What is the ASA physical status classification for a patient with Child‑Turcotte‑Pugh score 5 (cirrhosis class A) due to chronic hepatitis C, hepatocellular carcinoma, and diabetes mellitus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ASA Physical Status Classification: ASA III

For a patient with Child-Pugh score 5 (Class A cirrhosis), chronic hepatitis C, hepatocellular carcinoma, and diabetes mellitus, the appropriate ASA classification is ASA III (severe systemic disease).

Rationale for ASA III Classification

This patient has multiple severe systemic diseases that are not incapacitating but significantly impact perioperative risk:

  • Compensated cirrhosis (Child-Pugh A): While Child-Pugh 5 represents the mildest form of cirrhosis, it still indicates chronic liver disease with functional impairment 1
  • Hepatocellular carcinoma: Active malignancy requiring treatment
  • Diabetes mellitus: Chronic metabolic disease that compounds risk in HCV-related cirrhosis 2
  • Hepatitis C: Underlying chronic viral infection

Key Clinical Considerations

Why Not ASA II?

ASA II is reserved for mild systemic disease without substantive functional limitations. This patient has:

  • Active cancer (HCC)
  • Cirrhosis (even if compensated)
  • Multiple comorbidities that interact synergistically

The combination of HCV-related cirrhosis with diabetes significantly increases HCC risk and worsens outcomes 2, elevating this beyond "mild" disease.

Why Not ASA IV?

ASA IV requires severe systemic disease that is a constant threat to life. Child-Pugh A cirrhosis (score 5) represents compensated liver disease. The patient lacks:

  • Child-Pugh B or C cirrhosis
  • Decompensated liver disease (ascites, encephalopathy)
  • Life-threatening complications requiring immediate intervention

Evidence-Based Context

Perioperative risk assessment tools consistently identify Child-Pugh class and diabetes as important predictors of outcomes 1. The Breitenstein score assigns points for ASA III classification when evaluating post-hepatectomy complications 1, and multiple algorithms use ASA status as a key variable in risk stratification.

The presence of diabetes in HCV-related cirrhosis further heightens HCC risk (RR 1.74) 2 and complicates management due to altered drug metabolism and hypoglycemia risk 3.

Common Pitfalls to Avoid

  • Don't underestimate compensated cirrhosis: Child-Pugh A still represents significant liver dysfunction with portal hypertension risk 1
  • Don't ignore the synergistic effect: HCV + diabetes + HCC creates cumulative risk beyond individual conditions 4, 2
  • Don't confuse functional status with disease severity: Even if the patient is ambulatory and functional, multiple severe systemic diseases warrant ASA III

The ASA classification should reflect the aggregate burden of disease, not just the most prominent single condition 5, 6.

Related Questions

What is the appropriate American Society of Anesthesiologists (ASA) physical status classification for an 81-year-old patient with hypertension, chronic kidney disease stage 3a, hypercholesterolemia, and malignant melanoma?
Which antidiabetic medications are safe to use in a patient with compensated cirrhosis (Child‑Pugh class A, score 5)?
What is the ASA (American Society of Anesthesiologists) classification for an 89-year-old female with type 2 diabetes mellitus on insulin, asthma, hypertension, and chronic kidney disease stage 2?
What American Society of Anesthesiologists (ASA) physical status classification applies to a 70‑kg adult needing nutritional support with no major organ failure but likely mild chronic conditions?
What are the recommended blood glucose monitoring and management strategies for a patient with liver cirrhosis?
Are constitutional symptoms more common in Wegener's granulomatosis (granulomatosis with polyangiitis) or Churg‑Strauss syndrome (eosinophilic granulomatosis with polyangiitis)?
Is vaccination within the past 7 days a contraindication to general anesthesia?
Is albumin administration indicated in septic shock?
Is NPO (nil per os) required before an interventional radiology small tunneled catheter placement?
What is the appropriate treatment for post‑cerebrovascular accident (CVA) heaviness in the head and unilateral facial numbness?
Is a combination of prednisolone 50 mg, ranitidine 150 mg, loratadine 10 mg, and promethazine (Phenergan) 25 mg appropriate for managing an allergic reaction in the emergency department?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.